▲ BUY
8
/ 10
Conviction
$ Value
$27.9M
Shares
1,470,000
Price
$19
Filed
Dec 15
▶ Why this score? (8/10)
- ✓ Open market buy (+3)
- ✓ Trade value >= $5.0M (+3)
- ✓ 10%+ owner (+1)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
GSK plc
Title
—
CIK
0001131399
Roles
10% Owner
Transaction Details
Transaction Date
2025-12-11
Code
P
Table
Non-Derivative
Ownership
Indirect
Equity Swap
No
Shares After
18,245,691
Footnotes
The shares reported herein are held of record by Glaxo Group Limited, a wholly-owned subsidiary of GSK plc (the "Reporting Person").
Filing Info
GSK plc's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-12-11 | WVE | ▲ | $27.9M ★ |
Other Insiders at WVE (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $54.6M | — | 2026-03-30 |
|
Vargeese Chandra
See Remarks
|
— | $43K | 2026-02-09 |
|
Francis Chris
See Remarks
|
— | $525K | 2026-02-26 |
|
BOLNO PAUL
President and CEO
|
— | $141K | 2026-02-09 |
|
Moran Kyle
Chief Financial Officer
|
— | $48K | 2026-02-09 |
| TAKANASHI KEN | — | — | 2026-03-23 |